Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

1.12
Delayed Data
As of Jun 27
 -0.03 / -2.61%
Today’s Change
0.83
Today|||52-Week Range
5.36
-46.67%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close1.15
Today’s open1.15
Day’s range1.12 - 1.15
Volume100,823
Average volume (3 months)434,746
Market cap$31.7M
Dividend yield--
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+28.46%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-0.04-2.82%
TNXPTonix Pharmaceutical...-0.07-1.62%
CATBCatabasis Pharmaceut...+0.01+0.73%
VKTXViking Therapeutics ...-0.01-0.92%
Data as of 3:59pm ET, 06/27/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
David C. Baker
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts